NEW YORK, Feb. 21, 2018 /PRNewswire/ -- DFB Healthcare Acquisitions Corp. (NASDAQ: DFBHU) ("DFB Healthcare") announced todaythat it closed its initial public offering of 25,000,000 units. The offering was priced at $10.00 per unit, resulting in gross proceeds of $250,000,000.
The Company's units began trading
DFB Healthcare is sponsored by Deerfield/RAB Ventures, LLC, which was jointly founded by Deerfield Management Company L.P. ("Deerfield") and DFB Healthcare's management team, led by CEO Richard Barasch. Deerfield is an investment firm focused exclusively on the healthcare industry, and its investment activity spans both public and private securities. Mr. Barasch has more than 30 years of experience in healthcare services, health insurance, and related industries, and was CEO of Universal American Corp. from 1995 until the Company's acquisition by WellCare Health Plans in April 2017.
Goldman Sachs & Co. and Deutsche Bank Securities acted as joint book runners for the offering and Leerink Partners acted as co-manager. DFB Healthcare has granted the underwriters a 45-day option to purchase up to an additional 3,750,000 units at the initial public offering price to cover over-allotments, if any.
A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission on February 15, 2018. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The registration statement can be obtained at www.sec.gov.
About DFB Healthcare Acquisitions Corp.
DFB Healthcare Acquisitions Corp. is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It has not identified any business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with respect to identifying any business combination target. Its acquisition and value creation strategy will be to identify and acquire a business in the healthcare sector.
The offering was made only by means of a prospectus, copies of which may be obtained from Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, NY 10282, or by telephone toll-free at 1-866-471-2526 or by email at firstname.lastname@example.org, from Deutsche Bank Securities Inc., Attention: Prospectus Group, 60 Wall Street, New York, New York 10005-2836 (Tel: (800) 503-4611; Email: prospectus.CPDG@db.com), and from Leerink Partners LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, by telephone at 800-808-7525, ext. 6132 or by email at email@example.com.
DFB Healthcare Acquisitions Corp.Chris Wolfe, (212) firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/dfb-healthcare-acquisitions-corp-closes-250-million-initial-public-offering-300602395.html
SOURCE DFB Healthcare Acquisitions Corp.
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All